RxDoctor Payments Data

Susan Scanland

Gerontology · Scranton, PANPI 1740242064

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $359,627 of the $516,869 with a category attached, or 69.6%. Teva Pharmaceuticals USA, Inc. accounts for 70.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $175,386 and has fallen 74.3% since, to $45,052 in 2025. Among gerontology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$516,869in general payments, 2019–2025

Across 648 payments — averaging $797.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$363K
  • Acadia Pharmaceuticals Inc$99K
  • Otsuka America Pharmaceutical, Inc.$14K
  • Bioxcel Therapeutics, Inc.$13K
  • Eisai Inc.$11K
  • Axsome Therapeutics, Inc.$10K
  • plus $7K from 7 others

What the payments were for

  • Consulting fees$70,61214%
  • Speaking & faculty fees$359,62770%
  • Travel & lodging$73,68914%
  • Food & beverage$12,9403%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$516,869 in reported general payments places this provider in the 95th percentile of 383 gerontology providers in Pennsylvania.

See all gerontology providers in Pennsylvania

Other gerontology in Scranton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →